Dr. Chukwuma E. Eze, M.D.
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- Eastern Virginia Medical School (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 441
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Eastern Virginia Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
OH license 35.090623 -
Internal Medicine Physician
LA license MD025756
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Miami Valley Hospital Dayton, OH
- Kettering Health Dayton Dayton, OH
- Kettering Health Miamisburg Miamisburg, OH
Medical groups
- Renal Physicians Inc (29 clinicians)
- Fresenius Vascular Care Dayton LLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 441
- Services billed
- 1,672
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,380 | 21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 301 | 138 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 219 | 124 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 165 | 131 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 148 | 113 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 92 | 86 |
| Established patient office or other outpatient visit, 30-39 minutes | 86 | 63 |
| Hemodialysis procedure with physician evaluation | 59 | 43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 58 | 35 |
| Review by radiologist of arm or leg artery image | 40 | 37 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Furosemide Other prescribers in Dayton, OH | 86 |
| Calcitriol Other prescribers in Dayton, OH | 68 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Dayton, OH | 51 |
| Amlodipine Besylate Other prescribers in Dayton, OH | 47 |
| Spironolactone Other prescribers in Dayton, OH | 43 |
| Rayaldee (calcifediol) | 40 |
| Allopurinol Other prescribers in Dayton, OH | 35 |
| Losartan Potassium Other prescribers in Dayton, OH | 30 |
| Nifedipine Er (nifedipine) Other prescribers in Dayton, OH | 29 |
| Potassium Chloride Other prescribers in Dayton, OH | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 11 payments worth $221 in total to this clinician.
| Bard Peripheral Vascular, Inc. | $40.68 |
|---|---|
| Novartis Pharmaceuticals Corporation | $35.96 |
| Bayer HealthCare Pharmaceuticals Inc. | $34.97 |
| Amgen Inc. | $33.35 |
| Otsuka America Pharmaceutical, Inc. | $23.41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.67 |
| Calliditas Therapeutics US Inc. | $17.95 |
| Novo Nordisk Inc | $14.26 |
| Food and Beverage | $221 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.